Research output per year
Research output per year
Personal profile
Expertises
Clinical Oncologist working with Phase 1 Oncology trials since 2005. ESMO board certified in Medical Oncology. Professor in Clinical Oncology with special focus on personalized medicine. Established the Phase 1 Unit at Rigshospitalet in 2005, and established Copenhagen Prospective Personalized Oncology program (CoPPO) in 2013.
Main research areas
Early drug development
Precision Medicine and patient selection based on sequencing platforms
Translational Research with identification of predictive markers
Current research
Principal investigator in > 10 ongoing Phase 1 trials (including first in humans studies). Project leader of CoPPO. Principal supervisor of 6 PH.D.-projects in the field of Precision Medicine, translational research and drug developments. Co-supervisor of a number of other PH.D.-projects.
Potential conflicts of interest
None
Fingerprint
Dive into the research topics where Ulrik Lassen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Characteristics of de novo cancer in liver transplant recipients
Riis, T. H., Møller, D. L., Høgh, J., Knudsen, A. D., Rostved, A. A., Akdag, D., Kirkby, N., Lassen, U., Rasmussen, A., Hillingsø, J. G. & Pommergaard, H-C., 21 Jan 2023, (E-pub ahead of print) In: APMIS - Journal of Pathology, Microbiology and Immunology.Research output: Contribution to journal › Journal article › Research › peer-review
-
Radiotherapy Combined With Nivolumab or Temozolomide for Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter: An international randomized phase III trial
Omuro, A., Brandes, A. A., Carpentier, A. F., Idbaih, A., Reardon, D. A., Cloughesy, T., Sumrall, A., Baehring, J., van den Bent, M., Bähr, O., Lombardi, G., Mulholland, P., Tabatabai, G., Lassen, U., Sepulveda, J. M., Khasraw, M., Vauleon, E., Muragaki, Y., Di Giacomo, A. M., Butowski, N., & 9 others, 5 Jan 2023, In: Neuro-Oncology. 25, 1, p. 123-134 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World Data
Bokemeyer, C., Paracha, N., Lassen, U., Italiano, A., Sullivan, S. D., Marian, M., Brega, N. & Garcia-Foncillas, J., Jan 2023, In: JCO Precision Oncology. 7, p. e2200436Research output: Contribution to journal › Journal article › Research › peer-review
-
Changes in key recruitment performance metrics from 2008-2019 in industry-sponsored phase III clinical trials registered at ClinicalTrials.gov
Brøgger-Mikkelsen, M., Zibert, J. R., Andersen, A. D., Lassen, U., Hædersdal, M., Ali, Z. & Thomsen, S. F., 2022, In: PLoS One. 17, 7, p. e0271819 e0271819.Research output: Contribution to journal › Journal article › Research › peer-review
-
Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2-expressing normal lung
Lazar, V., Raynaud, J., Magidi, S., Bresson, C., Martini, J-F., Galbraith, S., Wunder, F., Onn, A., Batist, G., Girard, N., Lassen, U., Pramesh, C. S., Al-Omari, A., Ikeda, S., Berchem, G., Blay, J-Y., Solomon, B., Felip, E., Tabernero, J., Rubin, E., & 5 others, 2022, In: Therapeutic advances in medical oncology. 14, p. 17588359221133893Research output: Contribution to journal › Journal article › Research › peer-review